跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Vertset - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Vertset
Approved
STANDARD
Vertset
Globela Pharma Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d215f15b0e8f7b9e
Company
Globela Pharma Private Limited
Type
Standard
Approval Details
Approval Id
d215f15b0e8f7b9e
Drug Approval Philippines Name
Vertset
Product Name
Vertset
Registration Number
DRP-11798
Brand Name
Vertset
Generic Name
Betahistine Hydrochloride
Dosage Form
Tablet
Dosage Strength
16 mg
Manufacturer
Globela Pharma Private Limited
Importer
AMB HK Enterprises Inc.
Distributor
AMB HK Enterprises Inc.
Issuance Date
29 April 2022
Expiry Date
29 April 2027
Pharmacologic Category
Antivertigo
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d215f15b0e8f7b9e
Type
Standard
Back to Philippines FDA Approvals